Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 57Breast 40Other hematologic neoplasm 21Genitourinary 15Sarcoma 14Thoracic 12CNS 10Plasma cell 8Gynecologic 7Endocrine 4Classical hematology 4Tumor-Agnostic 3Head & Neck 3Other solid neoplasm 2Gastrointestinal 2Dermatologic 2Other 1NET 1

Conditions

Retinoblastoma 1Childhood Solid Tumors 1

Interventions

Cisplatin 60Carboplatin 55Cyclophosphamide 47Pemetrexed 45Irinotecan 33pembrolizumab 32Paclitaxel 29Etoposide 29Gemcitabine 28Nivolumab 24Bevacizumab 24Interviews as Topic 23Vincristine 22Capecitabine 22Topotecan 20Filgrastim 20Early Intervention, Educational 20fludarabine 19Oxaliplatin 19Docetaxel 19Specimen Handling 18Drug Therapy 18Temozolomide 17Sorafenib 17Leucovorin 17Everolimus 17Educational Status 17Radiotherapy 16Methods 16Fluorouracil 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × pegfilgrastim × Other solid neoplasm × Clear all
NCT01783535 2024-04-16

Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma

St. Jude Children's Research Hospital

Phase 2 Active not recruiting
174 enrolled
Other solid neoplasm

Retinoblastoma

NCT02392793 2021-02-09

Talazoparib Plus Irinotecan With or Without Temozolomide in Children With Refractory or Recurrent Solid Malignancies

St. Jude Children's Research Hospital

Phase 1 Completed
43 enrolled
Other solid neoplasm

Childhood Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡